Expression in E. coli of finger‐domain lacking tissue‐type plasminogen activator with high fibrin affinity

Tissue‐type plasminogen activator Finger‐domain Fibrin affinity Plasmid E. coli tac promoter/operator Detroit 562 cell

[1]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.

[2]  B. Bennett,et al.  Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. , 1984, Journal of clinical pathology.

[3]  M. Rånby,et al.  Isolation of two variants of native one‐chain tissue plasminogen activator , 1982, FEBS letters.

[4]  W. Weimar,et al.  SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR , 1981, The Lancet.

[5]  O. Matsuo,et al.  Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus , 1981, Nature.

[6]  H. Jörnvall,et al.  Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneity , 1983, FEBS letters.

[7]  C. Korninger,et al.  Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. , 1982, The Journal of clinical investigation.

[8]  F. Van de Werf,et al.  Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. , 1984, The New England journal of medicine.

[9]  L. Patthy,et al.  Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activator , 1983, FEBS letters.

[10]  J. Soria,et al.  Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator. , 1984, Thrombosis research.

[11]  H. Okayama,et al.  High-efficiency cloning of full-length cDNA , 1982, Molecular and cellular biology.

[12]  O. Matsuo,et al.  Effect of urokinase on fibrinolysis and fibrinogenolysis. , 1982, The Japanese journal of physiology.

[13]  H. Bando,et al.  Monoclonal antibody to human tissue plasminogen activator. , 1984, Thrombosis research.

[14]  P. Seeburg,et al.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.

[15]  L. Flohé,et al.  The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[16]  W. Gunzler.  The primary structure of high molecular mass urokinase from human urine , 1982 .

[17]  O. Matsuo,et al.  Comparison of the Relative Fibrinogenolytic, Fibrinolytic and Thrombolytic Properties of Tissue Plasminogen Activator and Urokinase in Vitro , 1981, Thrombosis and Haemostasis.

[18]  F. Elgh,et al.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Grant,et al.  Letter: SI units. , 1974, Lancet.